![Hans-Eckart Radunz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans-Eckart Radunz has been Chief Scientific Officer of NanoDel Technologies GmbH since November 2003.
Prior to founding NanoDel Technologies, he was Head of Research for Merck KGaA. He has 30 years of operational experience in international pharma and chemical management, development and implementation of strategies for pharmaceutical development as well as the development of new businesses.
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK KGAA | Technik-/Wissenschafts-/F&E-Leiter | - |
NanoDel Technologies GmbH
 NanoDel Technologies GmbH Medical/Nursing ServicesHealth Services Develops therapeutics for the treatment of central nervous system (CNS) related diseases | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
NanoDel Technologies GmbH
NanoDel Technologies GmbH Medical/Nursing ServicesHealth Services Develops therapeutics for the treatment of central nervous system (CNS) related diseases | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
